European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Ultra-small Nanohybrides for Advanced Theranostics

Descripción del proyecto

Ultrapequeños y polifacéticos: materiales nanohíbridos para el diagnóstico y el tratamiento

Los materiales nanométricos han ganado popularidad como facilitadores de tecnologías combinadas de diagnóstico y tratamiento debido a su tamaño diminuto con capacidad de penetración y a sus propiedades funcionales únicas. Los nanohíbridos que contienen componentes orgánicos e inorgánicos, incluidos los metálicos, ofrecen una enorme oportunidad para la funcionalización de moléculas biológicas o bioactivas. El proyecto UNAT, financiado con fondos europeos, explorará las capacidades de los nanohíbridos de metal y carbono para obtener imágenes multimodales «in vivo» y establecer un tratamiento para tumores mediante radiación electromagnética. El diagnóstico y tratamiento del cáncer se evaluarán a través de una ambiciosa campaña de experimentos preclínicos «in vitro» e «in vivo».

Objetivo

Nowadays, research focusing on control and use of nanomaterials in different areas including life sciences has become a key driver of innovation. UNAT project aims at a systematic interdisciplinary study of metal-carbon nanohybrides (NHs) for advanced theranostic application. Indeed, development of NHs based on organic & inorganic moieties can synergistically or antagonistically influence functional properties of engineered nanotheranostic medicines. UNAT will develop innovative approaches for synthesis and multi-functional application of ultra-small (<10 nm) carbon-based NHs functionalized with various metal atoms for diagnostics and therapy of cancer. In particular, carbon cores of NHs will be chemically synthesized from biomasses and bio-wastes. The combination of pre-clinical in-vitro & in-vivo experiments will allow to evaluate theranostic potential of the NHs.
UNAT will associate an industrial partner from Greece (Bioemtech), a research and innovation center from Ukraine (Science Park) and 2 academic research groups from France (UCBL) and Italy (CNR). The uptake efficiency and specific localization of the NHs in biological cells depending on their intentionally designed surface chemistry will be studied in details. Extremely rich physico-chemical properties of the NHs will allow their application as universal multi-modal (MRI, PET, X-ray, Fluorescence, Photoacoustic) in-vivo bio-imaging agents. The multimodal imaging strategy will allow us to correlate the images obtained with the use of various imaging facilities to increase general reliability of visualization of the NHs localization in tumours. Various exciting electro-magnetic sources used for medical purposes will be simultaneously used for therapy of cancer tissues containing the incorporated NHs. Strongly complementary research experiences of the partners involved in UNAT and a high degree of cooperative integration between them will allow a deep scientific study of the theranostic potential of the NHs.

Coordinador

UNIVERSITE LYON 1 CLAUDE BERNARD
Aportación neta de la UEn
€ 142 600,00
Dirección
BOULEVARD DU 11 NOVEMBRE 1918 NUM43
69622 Villeurbanne Cedex
Francia

Ver en el mapa

Región
Auvergne-Rhône-Alpes Rhône-Alpes Rhône
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 142 600,00

Participantes (4)